Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 49

Pre-close trading update confirms 2020 trading ahead of expectations

Published12/01/2021

Read more
Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors

Published30/12/2020

Read more
Vectura provides update on GSK litigation

Published29/12/2020

Read more
Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus®

Published17/12/2020

Read more
Vectura Expands Capabilities to Handle and Develop Highly Potent Inhaled Drugs at its Facility in Chippenham, U.K.

Published14/12/2020

Read more
Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma

Published30/11/2020

Read more
Vectura provides update on GSK litigation

Published19/11/2020

Read more
Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…”

Published08/10/2020

Read more
Vectura shortlisted for ’Excellence in Pharma: Contract Services and Outsourcing’

Published24/09/2020

Read more
Status update on VR315 (US)

Published22/09/2020

Read more
2020 Interim Results

Published15/09/2020

Read more
Vectura partners with Monash University to support development of inhaled oxytocin to prevent postpartum haemorrhage

Published14/09/2020

Read more
1 2 3 5

Displaying 12 of 49